Thomas Oxley is the founder of Synchron. Synchron has raised $217M in total funding. Latest round: Series C. Based in New York City, USA.
Thomas Oxley is an Australian neurologist who co-founded and currently serves as CEO of Synchron. His company is focused on developing the Stentrode, an implantable brain-computer interface designed to help patients with severe paralysis communicate through thought.
Full founder directory · Investor directory · Company funding database · Fundraising library